Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
Using two antigen binding sites and a drug joined to the antibody by a linker, the two sites enable the ADC to bind to membrane proteins that are present in a cancer cell before the antibody component ...
Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...